11/14
07:39 am
trml
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024 [Yahoo! Finance]
Medium
Report
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024 [Yahoo! Finance]
11/14
07:30 am
trml
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024
Medium
Report
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024
11/13
09:50 am
trml
Prevent Blindness Declares Fifth Annual Thyroid Eye Disease Awareness Week as Nov. 18-24, 2024 [Yahoo! Finance]
Low
Report
Prevent Blindness Declares Fifth Annual Thyroid Eye Disease Awareness Week as Nov. 18-24, 2024 [Yahoo! Finance]
11/13
02:07 am
trml
Tourmaline Bio, Inc. Reports Third Quarter Financial Results [Yahoo! Finance]
Low
Report
Tourmaline Bio, Inc. Reports Third Quarter Financial Results [Yahoo! Finance]
11/11
12:13 pm
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) had its price target raised by analysts at HC Wainwright from $48.00 to $49.00. They now have a "buy" rating on the stock.
Low
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) had its price target raised by analysts at HC Wainwright from $48.00 to $49.00. They now have a "buy" rating on the stock.
11/7
07:30 am
trml
Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Low
Report
Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
10/31
07:30 am
trml
Tourmaline Bio to Present at Upcoming Investor Conferences
Medium
Report
Tourmaline Bio to Present at Upcoming Investor Conferences
10/16
08:10 am
trml
Keros Therapeutics names Yung Chyung as chief medical officer [Seeking Alpha]
Medium
Report
Keros Therapeutics names Yung Chyung as chief medical officer [Seeking Alpha]
10/16
07:43 am
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Medium
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
10/15
07:30 am
trml
Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024
Low
Report
Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024
10/11
07:45 am
trml
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress [Yahoo! Finance]
Medium
Report
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress [Yahoo! Finance]
10/11
07:30 am
trml
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
Medium
Report
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
10/8
07:30 am
trml
Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board
Medium
Report
Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board
9/3
07:53 am
trml
Tourmaline Bio to Present at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Tourmaline Bio to Present at Upcoming Investor Conferences [Yahoo! Finance]
9/3
07:45 am
trml
Tourmaline Bio to Present at Upcoming Investor Conferences
Low
Report
Tourmaline Bio to Present at Upcoming Investor Conferences